Rose Keith Dale
Transaction: 05/01/2026
OTHER
Change
0
Price
Not reported
Filing
05/20/2026
Type
OTHER
Lifeward Ltd.
LFWD • Medical - Devices
$6.98
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$19.52M
Growth
-49.8%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.52Healthy liquidity · 1.31Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$6.98
Change0.00%
Shares Out2.80M
Market Cap$19.52M
Enterprise Value$12.63M
52W Range4.14 - 10.56
Beta0.38
P/E-0.63
P/S0.89
P/B1.60
P/FCF-1.14
EV/Sales0.58
Price$6.98
Change0.00%
Shares Out2.80M
Market Cap$19.52M
Enterprise Value$12.63M
52W Range4.14 - 10.56
Beta0.38
P/E-0.63
P/S0.89
P/B1.60
P/FCF-1.14
EV/Sales0.58
EV/EBITDA-0.52
EV/FCF-0.74
Earnings Yield-157.94%
FCF Yield-87.53%
Dividend Yield0.00%
Gross Margin38.25%
Oper. Margin-76.66%
Profit Margin-90.38%
Debt/Eq0.52
Current Ratio1.31
Quick Ratio0.84
Revenue 5Y-49.79%
Target$10.00
Target Upside43.27%
Target Median$10.00
Target Range10.00 - 10.00
Volume16.48K
Avg Volume10.30K
EPS Surprise-6.36
Investment DNA
How strong this company looks for long-term investors
31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
56/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
48/100
Why this score▼
Manageable debt level · 0.52Healthy liquidity · 1.31Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
80/100
Bullish
Bullish
4
Hold
0
Bearish
1
Price Target
2026-08-16
Low
$102.00
Mean
$129.00
Median
$129.00
High
$156.00
Insider Transactions
Recent executive and insider activity
ORAMED PHARMACEUTICALS INC.
Transaction: 03/25/2026
OTHER
Change
+1,666,666
Price
$5.40
Filing
05/14/2026
Type
OTHER
ORAMED PHARMACEUTICALS INC.
Transaction: 03/25/2026
OTHER
Change
+1,666,666
Price
$5.40
Filing
05/14/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rose Keith Dale | OTHER | 0 | Not reported | 05/01/2026 | 05/20/2026 |
| ORAMED PHARMACEUTICALS INC. | OTHER | +1,666,666 | $5.40 | 03/25/2026 | 05/14/2026 |
| ORAMED PHARMACEUTICALS INC. | OTHER | +1,666,666 | $5.40 | 03/25/2026 | 05/14/2026 |
| ORAMED PHARMACEUTICALS INC. | OTHER | 0 | Not reported | 03/25/2026 | 05/14/2026 |
| Rozenbaum Moshe H | OTHER | 0 | Not reported | 03/25/2026 | 04/13/2026 |
| Rozenbaum Moshe H | BUY | +11,485 | Not reported | 03/25/2026 | 04/13/2026 |
| Sigsbee William Mark | OTHER | 0 | Not reported | 03/25/2026 | 04/13/2026 |
| Sigsbee William Mark | BUY | +11,485 | Not reported | 03/25/2026 | 04/13/2026 |
| Kidron Miriam | OTHER | 0 | Not reported | 03/25/2026 | 03/27/2026 |
| KIDRON NADAV | OTHER | 0 | Not reported | 03/25/2026 | 03/27/2026 |
| Reznick Yehuda | OTHER | 0 | Not reported | 03/25/2026 | 03/27/2026 |
| Kidron Miriam | BUY | +7,657 | Not reported | 03/25/2026 | 03/27/2026 |
| KIDRON NADAV | BUY | +7,657 | Not reported | 03/25/2026 | 03/27/2026 |
| Reznick Yehuda | BUY | +7,657 | Not reported | 03/25/2026 | 03/27/2026 |
| Grant William Mark | BUY | +172,698 | $6.53 | 03/25/2026 | 03/27/2026 |
| Adar Almog | BUY | +39,934 | $6.53 | 03/25/2026 | 03/27/2026 |
| Lynch Jeannine | BUY | +50,000 | Not reported | 12/11/2025 | 12/12/2025 |
| Lynch Jeannine | SELL | -1,591 | $0.64 | 09/02/2025 | 09/04/2025 |
| Adar Almog | BUY | +225,000 | $0.72 | 08/13/2025 | 08/13/2025 |
| Swinford Michael | BUY | +35,920 | Not reported | 08/01/2025 | 08/07/2025 |